Company Search:
Advanced Search
Sponsored Links
Biotie Therapies Corp Company Snapshot
Biotie Therapies Corp operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Biotie Therapies Corp with three other miscellaneous service companies in Europe: Oryzon Genomics Sa of Spain (2015 sales of 4.25 million Euro [US$4.67 million] ), IXICO PLC of the United Kingdom (£3.12 million [US$3.83 million] ), and Biofrontera AG which is based in Germany (4.14 million Euro [US$4.54 million] of which 100% was Pharmaceuticals).

Sales Analysis. Sales fell dramatically in 2015: During the year ended December of 2015, sales at Biotie Therapies Corp were 3.74 million Euro (US$4.10 million). This is a sharp decrease of 74.9% versus 2014, when the company's sales were 14.90 million Euro.
  Stock Performance Chart for Biotie Therapies Corp
  Stock Data: Recent Stock Performance:
  Current Price (9/23/2016): .29
(Figures in Euro)
1 Week n/a   13 Weeks n/a  
4 Weeks n/a   52 Weeks n/a  
Biotie Therapies Corp Key Data:
  Ticker: BTH1V Country: Finland
  Exchanges: DUS FRA HEL OTH Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2015 Sales 3,736,000
(Year Ending Jan 2016).
Employees: 38
  Currency: Euro Market Cap: 284,467,321
  Fiscal Yr Ends: December Shares Outstanding: 980,921,795
  Share Type: Osake Closely Held Shares: 674,024,884
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.